Evaluating a noise reduction algorithm for cochlear implant users

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess the effectiveness of a noise reduction algorithm in enhancing speech understanding for cochlear implant users aged 12 and older. Participants will be exposed to various listening situations where the algorithm will be implemented to evaluate its performance. The study focuses on post-lingually deafened individuals who have been using cochlear implants for at least six months, ensuring a consistent experience with the device. The primary goal is to determine if the algorithm can significantly improve communication in noisy environments.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* At least 12 years of age.
* Be post-lingually deafened cochlear implant recipients with at least 6 months experience regardless of manufacturer.
* The PI must also deem the child to be developmentally able to complete the experiments.

Exclusion Criteria:

• Anyone who is not a cochlear implant user or is aged under 12 years.

Where it's running

• Tisch Hospital
  New York, New York, United States Recruiting

Study contacts

• Principal investigator: David M. Landsberger — NYU Langone Health
• Study coordinator: David M. Landsberger
• Email: David.landsberger@nyulangone.com
• Phone: 212-263-8455

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Clemastine plus engineered sound to improve hearing in noisy environments for age-related central auditory processing disorder

  This trial will test whether taking clemastine while listening to engineered sounds helps people aged 45–65 with age-related central auditory processing disorder hear better in noisy places.

  Recruiting Phase 1/2 University of Colorado, Denver · Aurora, Colorado · NCT07304024

• Registry for patients with CABP2-related hearing impairment

  This study is collecting information from people with hearing loss caused by CABP2 gene changes to learn more about this condition and how it affects them.

  Recruiting University Medical Center Goettingen · Göttingen · NCT06680934

• Evaluating a new frequency allocation for cochlear implant users

  This study is testing whether a new sound setting for cochlear implant users can improve their hearing experience and satisfaction compared to the standard setting.

  Recruiting NYU Langone Health · New York, New York · NCT06663917

• Registry for patients with otoferlin-related hearing impairment

  This study is collecting information from people with otoferlin-related hearing loss to better understand the condition and help improve future treatments.

  Recruiting University Medical Center Goettingen · Goettigen, Lower Saxony · NCT05946057

• Improving hearing tests for infants with hearing loss using brain imaging

  This study tests if a new brain imaging technique can help audiologists make better decisions for infants with hearing loss while also checking if parents find the testing comfortable and acceptable.

  Recruiting at 2 sites The Bionics Institute of Australia · East Melbourne, Victoria and 4 other locations · NCT05847426

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.